ClinicalTrials.Veeva

Menu

Large-scale ex Vivo Expansion and Characterization of Two Kinds of MSC From Knee for Clinical Application

E

EMO Biomedicine

Status

Completed

Conditions

Knee Injuries

Treatments

Biological: MSC from synovial membrane and infrapatellar Fat Pad

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02386163
EMO-IF-MSC-01

Details and patient eligibility

About

According to many researches, mesenchymal stem cells (MSC) isolated from synovial membrane and infrapatellar fat pad have higher ex vivo proliferation capacity, multipotency and ability to undergo chondrogenesis.

Based on this concept, the investigators plan to get two removed tissues (synovial membrane and infrapatellar fat pad) from patients who have an operation of TKR (Total Knee Replacement). The investigators are going to isolate and expand MSC from these two tissues respectively, and then compare their characterization and potential for clinical application. In the other hand, the investigators plan to build techniques and procedures which comply with "Good Tissue Practices (GTP)".

Enrollment

6 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient who have an total knee replacement surgery

Exclusion criteria

Patient who don't sign the agreement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems